BE882703A - Nouveaux derives de omega-(4-diphenylmethyl-piperidino)-1-phenylalcanols et leur procede de preparation. - Google Patents

Nouveaux derives de omega-(4-diphenylmethyl-piperidino)-1-phenylalcanols et leur procede de preparation.

Info

Publication number
BE882703A
BE882703A BE0/200161A BE200161A BE882703A BE 882703 A BE882703 A BE 882703A BE 0/200161 A BE0/200161 A BE 0/200161A BE 200161 A BE200161 A BE 200161A BE 882703 A BE882703 A BE 882703A
Authority
BE
Belgium
Prior art keywords
phenylalcanols
diphenylmethyl
piperidino
derivatives
preparation process
Prior art date
Application number
BE0/200161A
Other languages
English (en)
Inventor
A Carr
J Dolfini
G Wright
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21845568&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE882703(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of BE882703A publication Critical patent/BE882703A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
BE0/200161A 1979-04-10 1980-04-09 Nouveaux derives de omega-(4-diphenylmethyl-piperidino)-1-phenylalcanols et leur procede de preparation. BE882703A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/028,813 US4254129A (en) 1979-04-10 1979-04-10 Piperidine derivatives

Publications (1)

Publication Number Publication Date
BE882703A true BE882703A (fr) 1980-07-31

Family

ID=21845568

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/200161A BE882703A (fr) 1979-04-10 1980-04-09 Nouveaux derives de omega-(4-diphenylmethyl-piperidino)-1-phenylalcanols et leur procede de preparation.

Country Status (19)

Country Link
US (1) US4254129A (fr)
JP (1) JPS55141469A (fr)
AT (1) AT376208B (fr)
AU (1) AU531146B2 (fr)
BE (1) BE882703A (fr)
CA (1) CA1123438A (fr)
CH (1) CH643245A5 (fr)
DE (1) DE3007498A1 (fr)
DK (1) DK153709C (fr)
ES (1) ES8103735A1 (fr)
FR (1) FR2453854A1 (fr)
IL (1) IL59158A (fr)
IT (1) IT1143960B (fr)
NL (2) NL190580C (fr)
NO (2) NO154521C (fr)
NZ (1) NZ192653A (fr)
PH (1) PH17023A (fr)
SE (1) SE448726B (fr)
ZA (1) ZA80332B (fr)

Families Citing this family (114)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR240018A1 (es) * 1987-10-07 1990-01-31 Merrell Pharma Inc Procedimiento para preparar una composicion que comprende derivados de piperidinoalcanol.
CN1053570C (zh) 1987-10-07 2000-06-21 默尔多药物公司 哌啶子基链烷醇的药用组合物-减充血剂复方的制备方法
US4929605A (en) * 1987-10-07 1990-05-29 Merrell Dow Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol derivatives
US4908372A (en) * 1988-10-13 1990-03-13 Merrell Dow Pharmaceuticals Inc. Antihistaminic piperidinyl benzimidazoles
ZA90341B (en) * 1989-01-23 1990-10-31 Merrell Dow Pharma Liquid pharmaceutical composition for piperidinoalkanol derivatives
DE3917241A1 (de) * 1989-05-26 1990-11-29 Schaper & Bruemmer Gmbh 4-(hydroxydiphenylmethyl)-1-piperidyl-phenylalkan-derivate
US5182097A (en) * 1991-02-14 1993-01-26 Virginia Commonwealth University Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
US5190029A (en) * 1991-02-14 1993-03-02 Virginia Commonwealth University Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
TW198008B (fr) * 1991-04-08 1993-01-11 Green Cross Corp
HU211019B (en) * 1991-12-02 1995-09-28 Richter Gedeon Vegyeszet Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds
EP0626968B1 (fr) * 1992-02-13 2001-09-26 Merrell Pharmaceuticals Inc. Derives piperidinyles thiacycliques
US5631375A (en) * 1992-04-10 1997-05-20 Merrell Pharmaceuticals, Inc. Process for piperidine derivatives
AU671822B2 (en) * 1992-04-10 1996-09-12 Aventisub Ii Inc. 4-diphenylmethyl piperidine derivatives and process for their preparation
JPH07506828A (ja) * 1992-05-11 1995-07-27 メレルダウファーマス−ティカルズ　インコーポレイテッド 肝臓が損われた患者での抗ヒスタミン剤としてのターフェナジン誘導体の用途
DE69334145T2 (de) † 1992-08-03 2008-01-24 Sepracor Inc., Marlborough Terfenadincarboxylat und die Behandlung von Hautreizung
US5654433A (en) * 1993-01-26 1997-08-05 Merrell Pharmaceuticals Inc. Process for piperidine derivatives
US20020007068A1 (en) 1999-07-16 2002-01-17 D'ambra Thomas E. Piperidine derivatives and process for their production
PT1026147E (pt) * 1993-06-24 2004-04-30 Albany Molecular Res Inc Compostos uteis como intermediarios na producao de derivados de piperidina
WO1995000480A1 (fr) 1993-06-25 1995-01-05 Merrell Pharmaceuticals Inc. Nouveaux intermediaires utilises dans la preparation de derives de piperidine 4-diphenylmethyl/diphenylmethoxy antihistaminiques
US6147216A (en) * 1993-06-25 2000-11-14 Merrell Pharmaceuticals Inc. Intermediates useful for the preparation of antihistaminic piperidine derivatives
WO1995010278A1 (fr) * 1993-10-15 1995-04-20 Hoechst Marion Roussel, Inc. Traitement des troubles allergiques par le carboxylate de terfenadine
ATE197544T1 (de) * 1993-10-25 2000-12-15 Merrell Pharma Inc Stabile pharmazeutische zubereitungen, die terfenadine und ibuprofen enthalten
ATE194328T1 (de) * 1994-05-16 2000-07-15 Merrell Pharma Inc Verfahren und diastereomere salze nützlich bei der racemattrennung von racemischer 4-(4-(4- (hydroxydiphenylmethyl)-1-piperidinyl)-1- hydroxybutyl)-alpha,alpha-dimethylphenyl essigsäure sowie entsprechende diastereomere salze
CN101497581B (zh) * 1994-05-18 2012-07-11 安万特萨博Ⅱ有限公司 抗组胺哌啶衍生物,其多晶形物和假同晶物的无水和水合物形式的制备方法
US20030045722A1 (en) * 1994-05-18 2003-03-06 Henton Daniel R. Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
MX9605613A (es) * 1994-05-18 1998-05-31 Hoechst Marion Roussel Inc Procedimiento para preparar formas anhidras e hidratadas de derivados de piperidina antihistaminica, polimorfos y pseudomorfos de los mismos.
KR100362620B1 (ko) 1994-08-25 2003-02-14 메렐 파마슈티칼스 인크. 알레르기성질환치료에유용한치환된피페리딘,이를포함하는약제학적조성물및이의제조방법
EP0812195B1 (fr) * 1995-02-28 2002-10-30 Aventis Pharmaceuticals Inc. Composition pharmaceutique pour composes de piperidinoalcanol
CA2216877A1 (fr) * 1995-05-08 1996-11-14 Hoechst Marion Roussel, Inc. Derives butanol d'alpha-(alkylphenyl substitue)-4-(hydroxydiphenylmethyl)-1-piperidine, leur preparation et leur utilisation en tant qu'agents antihistaminiques, antiallergiques et dilatateurs bronchiques
US5574045A (en) * 1995-06-06 1996-11-12 Hoechst Marion Roussel, Inc. Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
US5906747A (en) * 1995-11-13 1999-05-25 Biosepra Inc. Separation of molecules from dilute solutions using composite chromatography media having high dynamic sorptive capacity at high flow rates
US6211199B1 (en) 1995-11-17 2001-04-03 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
US6194406B1 (en) 1995-12-20 2001-02-27 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease
US6423704B2 (en) 1995-12-20 2002-07-23 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
US6201124B1 (en) 1995-12-21 2001-03-13 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US6153754A (en) 1995-12-21 2000-11-28 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US5932571A (en) * 1996-02-21 1999-08-03 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases
US5998439A (en) * 1996-02-21 1999-12-07 Hoescht Marion Roussel, Inc. Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
US5922737A (en) * 1996-02-21 1999-07-13 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
US5925761A (en) * 1997-02-04 1999-07-20 Sepracor Inc. Synthesis of terfenadine and derivatives
DE59810863D1 (de) * 1997-03-11 2004-04-08 Aventis Pharma Inc Verfahren zur Herstellung von 4-(4-(4-(Hydroxydiphenyl)-1-piperidinyl)-1-hydroxybutyl)-alpha,alpha-dimenthylphenylessigsäure und phosphorylierter Derivate
US6451815B1 (en) 1997-08-14 2002-09-17 Aventis Pharmaceuticals Inc. Method of enhancing bioavailability of fexofenadine and its derivatives
PT998272E (pt) * 1997-08-26 2003-09-30 Aventis Pharma Inc Composicao farmaceutica para combinacao do descongestionante piperidinoalcanol
DK0924196T3 (da) * 1997-12-17 2003-09-29 Aventis Pharma Gmbh Fremgangsmåde til alkylering af alkyl- eller benzylcyanderivater i nærværelse af trialkylaminer eller -phosphiner
SK286103B6 (sk) * 1997-12-23 2008-03-05 Schering Corporation Farmaceutický prostriedok na liečenie respiračných a kožných ochorení s obsahom aspoň jedného antagonistu leukotriénu a aspoň jedného antihistaminikaa jeho použitie
US6194431B1 (en) 1998-04-14 2001-02-27 Paul D. Rubin Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
US6683094B2 (en) 1998-07-02 2004-01-27 Aventis Pharmaceuticals Inc. Antihistaminic piperidine derivatives and intermediates for the preparation thereof
NZ528839A (en) * 1998-07-02 2005-03-24 Aventis Pharma Inc Antihistaminic piperidine derivatives and intermediates
AU2007200674C1 (en) * 1998-07-02 2011-02-24 Aventisub Llc Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof
US6673933B2 (en) 1998-07-02 2004-01-06 Aventis Pharmaceutical Inc. Antihistaminic piperidine derivatives and intermediates for the preparation thereof
GB9822170D0 (en) * 1998-10-13 1998-12-02 Danbioyst Uk Ltd Novel formulations of fexofenadine
IN191492B (fr) * 1999-05-25 2003-12-06 Ranbaxy Lab Ltd
US6613906B1 (en) * 2000-06-06 2003-09-02 Geneva Pharmaceuticals, Inc. Crystal modification
US6613907B2 (en) 2000-11-08 2003-09-02 Amr Technology, Inc. Process for the production of piperidine derivatives with microorganisms
CH695216A5 (de) * 2001-02-23 2006-01-31 Cilag Ag Verfahren zur Herstellung eines nicht hydratisierten Salzes eines Piperidinderivats und eine so erhältliche neue kristalline Form eines solchen Salzes.
US20020177608A1 (en) * 2001-04-09 2002-11-28 Ben-Zion Dolitzky Polymorphs of fexofenadine hydrochloride
US20030021849A1 (en) * 2001-04-09 2003-01-30 Ben-Zion Dolitzky Polymorphs of fexofenadine hydrochloride
US7700779B2 (en) 2001-06-18 2010-04-20 Dr. Reddy's Laboratories Limited Crystalline forms of fexofenadine and its hydrochloride
CA2646802A1 (fr) 2001-06-18 2002-12-27 Dr. Reddy's Laboratories Ltd. Nouvelles formes cristallines d'acide 4-(4-(4-(hydroxydiphenylmethyl)-piperidin-1-yl)-1-hydroxybutyl)-alpha,alpha-dimethylbenzene-acetique et de son chlorhydrate
AU2002357701A1 (en) * 2001-11-08 2003-05-19 Teva Pharmaceutical Industries Ltd. Polymorphs of fexofenadine base
US20030158227A1 (en) * 2001-11-08 2003-08-21 Barnaba Krochmal Polymorphs of fexofenadine base
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
EP2266590A3 (fr) 2002-02-22 2011-04-20 Shire LLC Système d'administration de substances actives et méthodes de protection et d'administration de substances actives
AU2003248657A1 (en) * 2002-06-10 2003-12-22 Teva Pharmaceutical Industries Ltd. Polymorphic form xvi of fexofenadine hydrochloride
WO2004054955A1 (fr) * 2002-12-16 2004-07-01 Ranbaxy Laboratories Limited Procede de preparation de la fexofenadine
BRPI0407179A (pt) * 2003-01-31 2006-02-07 Ranbaxy Lab Ltd Processo para a preparação de fexodenadina
US20050065183A1 (en) * 2003-07-31 2005-03-24 Indranil Nandi Fexofenadine composition and process for preparing
US20050026890A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
GB0319935D0 (en) * 2003-08-26 2003-09-24 Cipla Ltd Polymorphs
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
JP2007532687A (ja) * 2004-04-26 2007-11-15 テバ ファーマシューティカル インダストリーズ リミティド フェキソフェナジン塩酸塩の結晶形およびその製造方法
WO2006008567A1 (fr) * 2004-06-18 2006-01-26 Wockhardt Limited Compositions pharmaceutiques a base de composes piperidinoalcanols
ITMI20041568A1 (it) * 2004-07-30 2004-10-30 Dipharma Spa "polimorfi di fexofenadina base"
US7498345B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US7498443B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of carebastine
JP2008514641A (ja) * 2004-09-28 2008-05-08 テバ ファーマシューティカル インダストリーズ リミティド 結晶形フェキソフェナジン、およびその調製方法
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
PT2522365T (pt) 2004-11-24 2017-02-08 Meda Pharmaceuticals Inc Composições que compreendem azelastina e seus métodos de utilização
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
JP2008120684A (ja) * 2005-03-07 2008-05-29 Kumamoto Univ 抗アレルギー薬
WO2007017905A1 (fr) * 2005-08-05 2007-02-15 Lupin Limited Compositions pharmaceutiques de fexofenadine sous forme de suspension et destinees a une administration par voie orale
US20070088065A1 (en) * 2005-10-14 2007-04-19 Jie Du Metaxalone products, method of manufacture, and method of use
US20080292584A1 (en) * 2005-10-14 2008-11-27 Mutual Pharmaceutical Company, Inc. Metaxalone products, method of manufacture, and method of use
WO2007049303A2 (fr) * 2005-10-28 2007-05-03 Ind-Swift Laboratories Limited Procede ameliore pour preparer de la fexofenadine a purete elevee
JP2009514969A (ja) 2005-11-09 2009-04-09 コンビナトアールエックス インコーポレーティッド 医学的状態を治療するための方法、組成物、およびキット
DOP2006000274A (es) * 2005-12-14 2007-10-15 Sanofi Aventis Us Llc Formulación de suspensión de fexofenadina
CN100443470C (zh) * 2006-07-21 2008-12-17 杭州保灵有限公司 一种依巴斯汀的制备方法
ITMI20061491A1 (it) * 2006-07-27 2008-01-28 Archimica Srl Processo per la preparazione di fexofenadina.
ITMI20061492A1 (it) * 2006-07-27 2008-01-28 Archimica Srl Processo per la preparazione di fexofenadina.
WO2008033466A2 (fr) * 2006-09-14 2008-03-20 Combinatorx (Singapore) Pre. Ltd. Compositions et procédés pour le traitement de maladies virales
CA2681267C (fr) 2007-04-13 2013-11-19 Southern Research Institute Agents anti-angiogeniques et procedes d'utilisation
ITMI20070987A1 (it) * 2007-05-16 2008-11-17 Dipharma Francis Srl Procedimento per la preparazione di composti chetonici
US20090076080A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched fexofenadine
EP2105134A1 (fr) 2008-03-24 2009-09-30 Ranbaxy Laboratories Limited Hydrochlorure de fexofenadine amorphe stable
CA2724607A1 (fr) * 2008-05-30 2009-12-31 Fairfield Clinical Trials, Llc Procede et composition pour une inflammation et une decoloration de la peau
WO2010021681A2 (fr) * 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions et procédés pour le traitement de maladies virales
CN101585805B (zh) * 2009-06-06 2011-07-06 浙江大学宁波理工学院 一种抗过敏药物非索非那定盐酸盐的制备方法
EP2289867A3 (fr) 2009-08-19 2012-04-25 Jubilant Organosys Limited Procédé de production d'acide acétique 4-(4-halo-1-oxybutyl)-alpha, alpha-dimethylbenzene ou esthers d'alkyle associés
CN101671292B (zh) * 2009-10-10 2011-09-07 浙江大学宁波理工学院 盐酸非索非那定的合成方法
US20110130711A1 (en) * 2009-11-19 2011-06-02 Follica, Inc. Hair growth treatment
EP2371817A1 (fr) * 2010-04-01 2011-10-05 Arevipharma GmbH Procédé pour la préparation de 1-[4-(1,1-diméthyléthyl)phényl]-4-[4-(diphénylméthoxy)-1-pipéridinyl]-1-butanone et de sels d'addition acides correspondant
WO2011158262A1 (fr) 2010-06-15 2011-12-22 Chemelectiva S.R.L. Forme polymorphe du chlorhydrate de fexofénadine, intermédiaires et procédé de préparation
EP2714624B1 (fr) 2011-05-23 2017-12-27 Sanofi Procédé pour la préparation de composés deutériés contenant des groupes n-alkyle
JP5362151B2 (ja) 2011-09-29 2013-12-11 塩野義製薬株式会社 Ｐｇｄ２拮抗剤及びヒスタミン拮抗剤からなるアレルギー性鼻炎治療用医薬
EP2578570A1 (fr) 2011-10-07 2013-04-10 Almirall, S.A. Nouveau procédé de fabrication de 5-(2-{[6-(2,2-difluoro-2-phényléthoxy)hexyl]amino}-1-hydroxyéthyl)-8-hydroxyquinolin-2(1h)-one via de nouveaux intermédiaires de synthèse
EP2641900A1 (fr) 2012-03-20 2013-09-25 Almirall, S.A. Nouvelles formes polymorphes de héminapadisylate de 5-(2-{[6-(2,2-difluoro-2-phényléthoxy) hexyl]amino}-1-(R)-hydroxyéthyl)-8-hydroxyquinolin-2(1h)-one en tant qu'agoniste du récepteur adrénergique ß2
CN102659667B (zh) * 2012-04-20 2013-08-14 浙江启明药业有限公司 一种非索非那定关键中间体的合成方法
CN103333100B (zh) * 2013-06-06 2016-04-06 池州东升药业有限公司 一种盐酸非索非那定的合成工艺
ITMI20131652A1 (it) 2013-10-07 2015-04-08 Dipharma Francis Srl Procedimento per la purificazione di derivati dell'acido 2-fenil-2-metil-propanoico
CN104557671B (zh) * 2013-10-10 2018-04-13 池州东升药业有限公司 一种非索非那定及中间体的合成方法
EP2949321A1 (fr) 2014-05-26 2015-12-02 Sanovel Ilac Sanayi ve Ticaret A.S. Formulations multicouche de fexofénadine et de montélukast
RS58961B1 (sr) 2015-01-22 2019-08-30 Sanofi Aventis Deutschland Proces proizvodnje 2-[4-(ciklopropankarbonil)fenil]-2-metil-propannitrila
US10696633B2 (en) 2015-10-22 2020-06-30 Sanofi-Aventis Deutschland Gmbh Process for the preparation of fexofenadine and of intermediates used therein
GB202212656D0 (en) 2022-08-31 2022-10-12 Novumgen Ltd An orodispersible tablet of fecofenadine and it process of preparation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1242169A (en) * 1969-04-09 1971-08-11 Ucb Sa Piperidine derivatives
ZA728544B (en) * 1972-01-28 1974-02-27 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
BE794596A (fr) * 1972-01-28 1973-05-16 Richardson Merrell Inc Piperidinoalcanone-oximes substituees et leur procede de preparation
US3878217A (en) * 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
US3965257A (en) * 1972-01-28 1976-06-22 Richardson-Merrell Inc. Compositions and methods for the treatment of the symptoms of histamine induced allergic reactions
BE794598A (fr) * 1972-01-28 1973-05-16 Richardson Merrell Inc Nouveaux derives olefiniques de piperidines substituees en 4 et leur procede de preparation
US3806526A (en) * 1972-01-28 1974-04-23 Richardson Merrell Inc 1-aroylalkyl-4-diphenylmethyl piperidines
US3931197A (en) * 1974-02-08 1976-01-06 Richardson-Merrell Inc. Substituted piperidine derivatives
US3941795A (en) * 1974-02-08 1976-03-02 Richardson-Merrell Inc. α-ARYL-4-SUBSTITUTED PIPERIDINOALKANOL DERIVATIVES
US3946022A (en) * 1974-03-04 1976-03-23 Richardson-Merrell Inc. Piperidine derivatives
US3922276A (en) * 1974-12-11 1975-11-25 Robins Co Inc A H 1-Substituted-4-benzylidenepiperidines
US3956296A (en) * 1974-12-11 1976-05-11 A. H. Robins Company, Incorporated 1-Substituted-4-benzylpiperidines

Also Published As

Publication number Publication date
US4254129A (en) 1981-03-03
ATA144880A (de) 1984-03-15
ES489934A0 (es) 1981-03-16
NL190580C (nl) 1994-05-02
JPS55141469A (en) 1980-11-05
CA1123438A (fr) 1982-05-11
IT1143960B (it) 1986-10-29
IL59158A (en) 1984-04-30
FR2453854A1 (fr) 1980-11-07
JPH0132823B2 (fr) 1989-07-10
NO801014L (no) 1980-10-13
DE3007498C2 (fr) 1989-09-07
NL980013I1 (nl) 1998-06-02
ZA80332B (en) 1981-01-28
CH643245A5 (de) 1984-05-30
FR2453854B1 (fr) 1983-06-24
DK132980A (da) 1980-10-11
PH17023A (en) 1984-05-11
NL980013I2 (nl) 1998-10-01
IL59158A0 (en) 1980-05-30
NO1998017I1 (no) 1998-05-29
NZ192653A (en) 1982-03-16
ES8103735A1 (es) 1981-03-16
DK153709C (da) 1988-12-27
AU531146B2 (en) 1983-08-11
NL8000754A (nl) 1980-10-14
IT8048245A0 (it) 1980-03-24
DK153709B (da) 1988-08-22
AU5501680A (en) 1980-10-16
AT376208B (de) 1984-10-25
NO154521C (no) 1986-10-08
DE3007498A1 (de) 1980-10-23
NO154521B (no) 1986-06-30
SE8002634L (sv) 1980-10-11
SE448726B (sv) 1987-03-16
NL190580B (nl) 1993-12-01

Similar Documents

Publication Publication Date Title
BE882703A (fr) Nouveaux derives de omega-(4-diphenylmethyl-piperidino)-1-phenylalcanols et leur procede de preparation.
BE882704A (fr) Nouveaux derives de omega-(4-diphenylmethyl-piperidino)-alcanophenones et leur procede de preparation
BE880844A (fr) Nouveaux derives de peptidyl-arginine-aldehydes et procede de preparation de ceux-ci
BE849794A (fr) Derives de carbostyrile et leur procede de preparation
FR2449699B1 (fr) Polyetherpolyamides et leur procede de preparation
FR2384753B1 (fr) Nouveaux thiols et leur procede de preparation
FR2340963A1 (fr) Polyestercarbonates aromatiques et leur procede de preparation
FR2349579A1 (fr) Derives de 1,2-dihydronaphtalene et leur procede de preparation
BE862422A (fr) Nouveaux derives de type succinimide et procede de leur preparation
BE847090A (fr) 15-steroides, et leur procede de preparation
MC1316A1 (fr) Ion nouveaux derives de flavone et procede pour leur preparat0
BE853411A (fr) Nouveaux derives phenoxybenzyloxycarbonyliques substitues, leur procede de preparation et leur application comme insecticides et acaricides
FR2299032A1 (fr) Derives de tetrahydroisoquinoleine et leur procede de preparation
FR2337719A1 (fr) Nouveaux triazolyl-o,n-acetals acyles, leur procede de preparation et leur application comme fongicides
BE865705A (fr) Nouveaux derives de prostane, leur procede de preparation et leur utilisation
BE885946A (fr) Nouvelles pyridothienotriazines et leur procede de preparation
FR2340927A1 (fr) Nouveaux derives de chloral, leur procede de preparation et leur application comme fongicides
BE856220A (fr) Polyether-polyureides et procede de leur preparation
BE882044A (fr) Derives de theobromine et leur procede de preparation
BE855236A (fr) Derives omega-nor-aromatiques de 13,14-dehydro-prostaglandines et procede pour leur preparation
BE858240A (fr) Nouveaux derives du benzopyranne et leur procede de preparation
BE884652R (fr) Phenoxyalcoyl trialcoxysilanes et leur procede de preparation
FR2353537A1 (fr) Nouveaux derives aminomethylazoliques, leur procede de preparation et l
FR2317930A1 (fr) Nouveaux derives d'apovincaminol, leur procede de preparation et leur application
BE873630A (fr) Nouveaux derives de fortimicine b et leur procede de preparation

Legal Events

Date Code Title Description
CN Change of patent owner's name
CCPV Grant of a supplementary protection certificate

Free format text: 097C0100, EXPIRES: 20050409

RE20 Patent expired

Owner name: MERRELL PHARMACEUTICALS INC.

Effective date: 20000409

CCRE Expiry of a supplementary protection certificate

Extension date: 20050409

CCRE Expiry of a supplementary protection certificate

Free format text: PRODUCT NAME: FEXOFENADINUM HYDROCHLORIDUM; NAT. REG. NO/DATE: 354 IS 355 F 3 19970414; FIRST REG.:GB PL 04425/0155 19960311

Spc suppl protection certif: 97C0100

Filing date: 19970902

Expiry date: 20000409

Extension date: 20050409